TAT-327

• Target :

  EGFR|||Apoptosis|||Complement System|||Interleukin|||IFNAR|||TNF

• Related Pathways :

  JAK/STAT signaling|||Angiogenesis|||Immunology/Inflammation|||Apoptosis|||Tyrosine Kinase/Adaptors

• Bioactivity :

  TAT-327 is a cell-penetrating peptide known for selectively inserting into cancer cell membranes and exhibiting potent anti-tumor activity. It effectively inhibits cancer cell proliferation, induces apoptosis, and disrupts the EGFR signaling pathway by suppressing the expression of downstream signals (such as IL-2, TNF-?, and IFN-?) and the interaction between Eps8 and EGFR. Additionally, TAT-327 significantly inhibits tumor growth in HT-29 xenograft models.

• Shipping Conditions :

  Cool pack

• Storage Temperature :

  -20°C